Committee for Proprietary Medicinal Products
E23504
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
All labels observed (2)
| Label | Occurrences |
|---|---|
| Committee for Proprietary Medicinal Products canonical | 5 |
| Committee for Medicinal Products for Human Use | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T184492 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Committee for Proprietary Medicinal Products Context triple: [European Medicines Agency, predecessor, Committee for Proprietary Medicinal Products]
-
A.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
B.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
C.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
-
D.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
E.
GlaxoSmithKline
GlaxoSmithKline is a global biopharmaceutical company known for developing and manufacturing prescription medicines, vaccines, and consumer healthcare products.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Committee for Proprietary Medicinal Products Target entity description: The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
-
A.
European Medicines Agency
The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
-
B.
UK Medicines and Healthcare products Regulatory Agency
The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
-
C.
European Directorate for the Quality of Medicines & HealthCare
The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
-
D.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
E.
GlaxoSmithKline
GlaxoSmithKline is a global biopharmaceutical company known for developing and manufacturing prescription medicines, vaccines, and consumer healthcare products.
- F. None of above. chosen
Statements (38)
| Predicate | Object |
|---|---|
| instanceOf |
regulatory committee
ⓘ
scientific committee ⓘ |
| appliesTo |
human medicinal products
ⓘ
medicinal products for human use authorised via the EU centralised procedure ⓘ |
| basedOn | EU pharmaceutical legislation ⓘ |
| collaboratesWith | national competent authorities of EU Member States ⓘ |
| country | European Union ⓘ |
| dissolvedIn | 2004 ⓘ |
| field |
medicinal products regulation
ⓘ
pharmacovigilance ⓘ public health ⓘ |
| hasAbbreviation | CPMP ⓘ |
| hasParentOrganization |
European Medicines Agency
ⓘ
surface form:
European Agency for the Evaluation of Medicinal Products
European Medicines Agency ⓘ |
| hasSuccessor | Committee for Medicinal Products for Human Use ⓘ |
| jurisdiction | European Union ⓘ |
| languageOfWork | English ⓘ |
| operatedBy | European Union ⓘ |
| operatedUnder |
European Union
ⓘ
surface form:
European Community
|
| partOf | European medicines regulatory system ⓘ |
| regulates | proprietary medicinal products ⓘ |
| regulatoryScope | centralised marketing authorisation procedure ⓘ |
| reorganizedInto | Committee for Medicinal Products for Human Use ⓘ |
| replacedBy |
Committee for Medicinal Products for Human Use
ⓘ
European Medicines Agency committee structure ⓘ |
| responsibleFor |
assessment of efficacy of medicines
ⓘ
assessment of quality of medicines ⓘ assessment of safety of medicines ⓘ evaluation of medicinal products ⓘ issuing scientific opinions on marketing authorisation applications ⓘ |
| sector |
healthcare regulation
ⓘ
pharmaceutical regulation ⓘ |
| supervisedBy | European Commission ⓘ |
| task |
adopt opinions on applications for marketing authorisation
ⓘ
evaluate benefit–risk balance of medicines ⓘ provide scientific advice to the European Commission ⓘ |
| workLocation |
London, England
ⓘ
surface form:
London
United Kingdom ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Committee for Proprietary Medicinal Products Description of subject: The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
Referenced by (6)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Committee for Medicinal Products for Human Use
Committee for Medicinal Products for Human Use
→
formerlyKnownAs
→
Committee for Proprietary Medicinal Products
ⓘ
Committee for Medicinal Products for Human Use
→
replaced
→
Committee for Proprietary Medicinal Products
ⓘ